Morphine-induced early delays in wound closure: Involvement of sensory neuropeptides and modification of neurokinin receptor expression

Jerri M. Rook, Wohaib Hasan, Kenneth E. McCarson

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Dose-limiting side effects of centrally acting opioid drugs have led to the use of topical opioids to reduce the pain associated with chronic cutaneous wounds. However, previous studies indicate that topical morphine application impairs wound healing. This study was designed to elucidate the mechanisms by which morphine delays wound closure. Rats were depleted of sensory neuropeptides by treatment with capsaicin, and full-thickness 4-mm diameter wounds were excised from the intrascapular region. Wounds were treated topically twice daily with 5 mM morphine sulfate, 1 mM substance P, 1 mM neurokinin A, or 5 mM morphine combined with 1 mM substance P or neurokinin A and wound areas assessed. During closure, wound tissue was taken 1, 3, 5, and 8 days post-wounding from control and morphine-treated rats and immunostained for neurokinin receptors and markers for macrophages, myofibroblasts, and vasculature. Results obtained from capsaicin-treated animals demonstrated a significant delay in the early stages of wound contraction that was reversed by neuropeptide application. Treatment of capsaicin-treated rats with topical morphine did not further delay wound closure, suggesting that topical opioids impair wound closure via the inhibition of peripheral neuropeptide release into the healing wound. Morphine application altered neurokinin-1 and neurokinin-2 receptor expression in inflammatory and parenchymal cells essential for wound healing in a cell-specific manner, demonstrating a direct effect of morphine on neurokinin receptor regulation within an array of cells involved in wound healing. These data provide evidence indicating a potentially detrimental effect of topical morphine application on the dynamic wound healing process.

Original languageEnglish (US)
Pages (from-to)1747-1755
Number of pages9
JournalBiochemical Pharmacology
Volume77
Issue number11
DOIs
StatePublished - Jun 1 2009
Externally publishedYes

Fingerprint

Neuropeptides
Morphine
Wounds and Injuries
Wound Healing
Capsaicin
Opioid Analgesics
Neurokinin A
Rats
Substance P
Neurokinin-2 Receptors
Myofibroblasts
Macrophages
Animals
Tissue
Pain
Skin
Therapeutics
Pharmaceutical Preparations

Keywords

  • Macrophage
  • Myofibroblast
  • Neurokinin A
  • Primary afferent neuron
  • Skin
  • Substance P

ASJC Scopus subject areas

  • Pharmacology
  • Biochemistry

Cite this

Morphine-induced early delays in wound closure : Involvement of sensory neuropeptides and modification of neurokinin receptor expression. / Rook, Jerri M.; Hasan, Wohaib; McCarson, Kenneth E.

In: Biochemical Pharmacology, Vol. 77, No. 11, 01.06.2009, p. 1747-1755.

Research output: Contribution to journalArticle

@article{1d2be045d1984001a61376adf2d39223,
title = "Morphine-induced early delays in wound closure: Involvement of sensory neuropeptides and modification of neurokinin receptor expression",
abstract = "Dose-limiting side effects of centrally acting opioid drugs have led to the use of topical opioids to reduce the pain associated with chronic cutaneous wounds. However, previous studies indicate that topical morphine application impairs wound healing. This study was designed to elucidate the mechanisms by which morphine delays wound closure. Rats were depleted of sensory neuropeptides by treatment with capsaicin, and full-thickness 4-mm diameter wounds were excised from the intrascapular region. Wounds were treated topically twice daily with 5 mM morphine sulfate, 1 mM substance P, 1 mM neurokinin A, or 5 mM morphine combined with 1 mM substance P or neurokinin A and wound areas assessed. During closure, wound tissue was taken 1, 3, 5, and 8 days post-wounding from control and morphine-treated rats and immunostained for neurokinin receptors and markers for macrophages, myofibroblasts, and vasculature. Results obtained from capsaicin-treated animals demonstrated a significant delay in the early stages of wound contraction that was reversed by neuropeptide application. Treatment of capsaicin-treated rats with topical morphine did not further delay wound closure, suggesting that topical opioids impair wound closure via the inhibition of peripheral neuropeptide release into the healing wound. Morphine application altered neurokinin-1 and neurokinin-2 receptor expression in inflammatory and parenchymal cells essential for wound healing in a cell-specific manner, demonstrating a direct effect of morphine on neurokinin receptor regulation within an array of cells involved in wound healing. These data provide evidence indicating a potentially detrimental effect of topical morphine application on the dynamic wound healing process.",
keywords = "Macrophage, Myofibroblast, Neurokinin A, Primary afferent neuron, Skin, Substance P",
author = "Rook, {Jerri M.} and Wohaib Hasan and McCarson, {Kenneth E.}",
year = "2009",
month = "6",
day = "1",
doi = "10.1016/j.bcp.2009.03.003",
language = "English (US)",
volume = "77",
pages = "1747--1755",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "11",

}

TY - JOUR

T1 - Morphine-induced early delays in wound closure

T2 - Involvement of sensory neuropeptides and modification of neurokinin receptor expression

AU - Rook, Jerri M.

AU - Hasan, Wohaib

AU - McCarson, Kenneth E.

PY - 2009/6/1

Y1 - 2009/6/1

N2 - Dose-limiting side effects of centrally acting opioid drugs have led to the use of topical opioids to reduce the pain associated with chronic cutaneous wounds. However, previous studies indicate that topical morphine application impairs wound healing. This study was designed to elucidate the mechanisms by which morphine delays wound closure. Rats were depleted of sensory neuropeptides by treatment with capsaicin, and full-thickness 4-mm diameter wounds were excised from the intrascapular region. Wounds were treated topically twice daily with 5 mM morphine sulfate, 1 mM substance P, 1 mM neurokinin A, or 5 mM morphine combined with 1 mM substance P or neurokinin A and wound areas assessed. During closure, wound tissue was taken 1, 3, 5, and 8 days post-wounding from control and morphine-treated rats and immunostained for neurokinin receptors and markers for macrophages, myofibroblasts, and vasculature. Results obtained from capsaicin-treated animals demonstrated a significant delay in the early stages of wound contraction that was reversed by neuropeptide application. Treatment of capsaicin-treated rats with topical morphine did not further delay wound closure, suggesting that topical opioids impair wound closure via the inhibition of peripheral neuropeptide release into the healing wound. Morphine application altered neurokinin-1 and neurokinin-2 receptor expression in inflammatory and parenchymal cells essential for wound healing in a cell-specific manner, demonstrating a direct effect of morphine on neurokinin receptor regulation within an array of cells involved in wound healing. These data provide evidence indicating a potentially detrimental effect of topical morphine application on the dynamic wound healing process.

AB - Dose-limiting side effects of centrally acting opioid drugs have led to the use of topical opioids to reduce the pain associated with chronic cutaneous wounds. However, previous studies indicate that topical morphine application impairs wound healing. This study was designed to elucidate the mechanisms by which morphine delays wound closure. Rats were depleted of sensory neuropeptides by treatment with capsaicin, and full-thickness 4-mm diameter wounds were excised from the intrascapular region. Wounds were treated topically twice daily with 5 mM morphine sulfate, 1 mM substance P, 1 mM neurokinin A, or 5 mM morphine combined with 1 mM substance P or neurokinin A and wound areas assessed. During closure, wound tissue was taken 1, 3, 5, and 8 days post-wounding from control and morphine-treated rats and immunostained for neurokinin receptors and markers for macrophages, myofibroblasts, and vasculature. Results obtained from capsaicin-treated animals demonstrated a significant delay in the early stages of wound contraction that was reversed by neuropeptide application. Treatment of capsaicin-treated rats with topical morphine did not further delay wound closure, suggesting that topical opioids impair wound closure via the inhibition of peripheral neuropeptide release into the healing wound. Morphine application altered neurokinin-1 and neurokinin-2 receptor expression in inflammatory and parenchymal cells essential for wound healing in a cell-specific manner, demonstrating a direct effect of morphine on neurokinin receptor regulation within an array of cells involved in wound healing. These data provide evidence indicating a potentially detrimental effect of topical morphine application on the dynamic wound healing process.

KW - Macrophage

KW - Myofibroblast

KW - Neurokinin A

KW - Primary afferent neuron

KW - Skin

KW - Substance P

UR - http://www.scopus.com/inward/record.url?scp=64249140130&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64249140130&partnerID=8YFLogxK

U2 - 10.1016/j.bcp.2009.03.003

DO - 10.1016/j.bcp.2009.03.003

M3 - Article

C2 - 19428329

AN - SCOPUS:64249140130

VL - 77

SP - 1747

EP - 1755

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 11

ER -